Literature DB >> 17037599

Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.

Benjamin W Neuman1, David A Stein, Andrew D Kroeker, Hong M Moulton, Richard K Bestwick, Patrick L Iversen, Michael J Buchmeier.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17037599      PMCID: PMC7123819          DOI: 10.1007/978-0-387-33012-9_103

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  17 in total

Review 1.  Morpholino antisense oligomers: the case for an RNase H-independent structural type.

Authors:  J Summerton
Journal:  Biochim Biophys Acta       Date:  1999-12-10

2.  A specificity comparison of four antisense types: morpholino, 2'-O-methyl RNA, DNA, and phosphorothioate DNA.

Authors:  D Stein; E Foster; S B Huang; D Weller; J Summerton
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-06

3.  Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA.

Authors:  R V Giles; D G Spiller; R E Clark; D M Tidd
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1999-04

4.  Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

Authors:  Usman Bacha; Jennifer Barrila; Adrian Velazquez-Campoy; Stephanie A Leavitt; Ernesto Freire
Journal:  Biochemistry       Date:  2004-05-04       Impact factor: 3.162

5.  Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth.

Authors:  Benjamin W Neuman; David A Stein; Andrew D Kroeker; Amy D Paulino; Hong M Moulton; Patrick L Iversen; Michael J Buchmeier
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.

Authors:  Zhi Wang; Lili Ren; Xingang Zhao; Tao Hung; Anming Meng; Jianwei Wang; Ye-Guang Chen
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.

Authors:  Berend Jan Bosch; Byron E E Martina; Ruurd Van Der Zee; Jean Lepault; Bert Jan Haijema; Cees Versluis; Albert J R Heck; Raoul De Groot; Albert D M E Osterhaus; Peter J M Rottier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

8.  Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.

Authors:  Paolo Ingallinella; Elisabetta Bianchi; Marco Finotto; Giovanna Cantoni; Debra M Eckert; Vinit M Supekar; Chiara Bruckmann; Andrea Carfi; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

9.  Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.

Authors:  Eric J Snijder; Peter J Bredenbeek; Jessika C Dobbe; Volker Thiel; John Ziebuhr; Leo L M Poon; Yi Guan; Mikhail Rozanov; Willy J M Spaan; Alexander E Gorbalenya
Journal:  J Mol Biol       Date:  2003-08-29       Impact factor: 5.469

10.  Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics.

Authors:  Richard Y Kao; Wayne H W Tsui; Terri S W Lee; Julian A Tanner; Rory M Watt; Jian-Dong Huang; Lihong Hu; Guanhua Chen; Zhiwei Chen; Linqi Zhang; Tian He; Kwok-Hung Chan; Herman Tse; Amanda P C To; Louisa W Y Ng; Bonnie C W Wong; Hoi-Wah Tsoi; Dan Yang; David D Ho; Kwok-Yung Yuen
Journal:  Chem Biol       Date:  2004-09
View more
  8 in total

1.  Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus.

Authors:  Yan-Jin Zhang; Rheba S Bonaparte; Deendayal Patel; David A Stein; Patrick L Iversen
Journal:  Mol Cancer Ther       Date:  2008-03       Impact factor: 6.261

2.  Inhibition of foot-and-mouth disease virus infections in cell cultures with antisense morpholino oligomers.

Authors:  Ariel Vagnozzi; David A Stein; Patrick L Iversen; Elizabeth Rieder
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

3.  Interference of ribosomal frameshifting by antisense peptide nucleic acids suppresses SARS coronavirus replication.

Authors:  Dae-Gyun Ahn; Wooseong Lee; Jin-Kyu Choi; Seong-Jun Kim; Ewan P Plant; Fernando Almazán; Deborah R Taylor; Luis Enjuanes; Jong-Won Oh
Journal:  Antiviral Res       Date:  2011-04-23       Impact factor: 5.970

Review 4.  Antisense Phosphorodiamidate Morpholino Oligomers as Novel Antiviral Compounds.

Authors:  Yuchen Nan; Yan-Jin Zhang
Journal:  Front Microbiol       Date:  2018-04-20       Impact factor: 5.640

Review 5.  Cell penetrating peptide conjugates of steric block oligonucleotides.

Authors:  Bernard Lebleu; Hong M Moulton; Rachida Abes; Gabriela D Ivanova; Said Abes; David A Stein; Patrick L Iversen; Andrey A Arzumanov; Michael J Gait
Journal:  Adv Drug Deliv Rev       Date:  2007-10-22       Impact factor: 15.470

Review 6.  Reducing SARS-CoV-2 pathological protein activity with small molecules.

Authors:  Donata Pluskota-Karwatka; Marcin Hoffmann; Jan Barciszewski
Journal:  J Pharm Anal       Date:  2021-04-05

Review 7.  The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses.

Authors:  Longping V Tse; Rita M Meganck; Rachel L Graham; Ralph S Baric
Journal:  Front Microbiol       Date:  2020-04-24       Impact factor: 5.640

Review 8.  Advances in oligonucleotide drug delivery.

Authors:  Thomas C Roberts; Robert Langer; Matthew J A Wood
Journal:  Nat Rev Drug Discov       Date:  2020-08-11       Impact factor: 84.694

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.